|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/44 | |
| A61K 31/4995 | |||
| A61K 31/517 | |||
| A61K 45/06 |
| (11) | Number of the document | 1962843 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06840026.6 |
| Date of filing the European patent application | 2006-11-27 | |
| (97) | Date of publication of the European application | 2008-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2011-02-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/061254 |
| Date | 2006-11-27 |
| (87) | Number | WO 2007/062413 |
| Date | 2007-05-31 |
| (30) | Number | Date | Country code |
| 739536 P | 2005-11-25 | US |
| (72) |
SCOTTO, Kathleen, A., US
MANDOLA, Michael, US
|
| (73) |
Pharma Mar S.A., Sociedad Unipersonal,
Polígono Industrial La Mina Avenida de los Reyes, 1 Colmenar Viejo, 28770 Madrid,
ES
|
| (54) | USE OF PARP-1 INHIBITORS |
| USE OF PARP-1 INHIBITORS |